Beta
Losing weight could now be easier than ever. Matthew Schneier discusses the rise of Ozempic, a diabetes drug moonlighting as an off-label appetite suppressant.
Weight loss startup Noom is now prescribing drugs
7 min
Ozempic settles the obesity debate: it’s biology over willpower
10 min
The other Ozempic revolution
20 min
WeightWatchers gets a makeover with obesity-drug business
5 min
The problematic arrival of anti-obesity drugs
12 min
The real-life implications of weight-loss injections
34 min